Samia Mora
#159,451
Most Influential Person Now
Researcher
Samia Mora's AcademicInfluence.com Rankings
Samia Moraphilosophy Degrees
Philosophy
#9146
World Rank
#12661
Historical Rank
Logic
#6137
World Rank
#7622
Historical Rank

Download Badge
Philosophy
Samia Mora's Degrees
- Doctorate Medicine Stanford University
Why Is Samia Mora Influential?
(Suggest an Edit or Addition)Samia Mora's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Discovery and Refinement of Loci Associated with Lipid Levels (2013) (2475)
- Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. (2007) (1547)
- Physical Activity and Reduced Risk of Cardiovascular Events: Potential Mediating Mechanisms (2007) (961)
- Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (2019) (933)
- Common variants associated with plasma triglycerides and risk for coronary artery disease (2013) (767)
- Marine n‐3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (2019) (572)
- Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. (2012) (532)
- Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. (2014) (513)
- Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children (2011) (508)
- Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Med (2016) (489)
- Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. (2003) (444)
- Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women (2009) (443)
- Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. (2006) (432)
- Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events (2008) (399)
- LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). (2007) (378)
- Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis (2009) (345)
- High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). (2012) (333)
- Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. (2011) (306)
- Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention An Intervention Trial Evaluating Rosuvastatin) (2013) (303)
- Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials (2018) (281)
- A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians (2014) (228)
- High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy (2013) (225)
- Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? (2006) (216)
- Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study (2004) (197)
- HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial (2010) (191)
- Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. (2007) (189)
- Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events (2014) (176)
- Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis (2013) (174)
- A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events (2014) (171)
- Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. (2009) (170)
- Lipoprotein(a) and risk of type 2 diabetes. (2010) (164)
- Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) (2017) (163)
- Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women (2010) (161)
- Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents. (2016) (159)
- Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy: The Treating to New Targets (TNT) Study (2012) (157)
- Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medi (2016) (151)
- Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM. (2018) (148)
- ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiova (2009) (136)
- The use of high-sensitivity assays for C-reactive protein in clinical practice (2008) (135)
- Exercise Blood Pressure and Future Cardiovascular Death in Asymptomatic Individuals (2010) (126)
- AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention (2009) (123)
- Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III) (2014) (120)
- Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women (2018) (115)
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM (2019) (111)
- Lipoprotein Particles and Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (2015) (110)
- The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. (2009) (105)
- Lipid biomarkers and long-term risk of cancer in the Women's Health Study. (2016) (105)
- Enhanced Risk Assessment in Asymptomatic Individuals With Exercise Testing and Framingham Risk Scores (2005) (98)
- Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol (2017) (96)
- Lifestyle Interaction With Fat Mass and Obesity-Associated (FTO) Genotype and Risk of Obesity in Apparently Healthy U.S. Women (2011) (96)
- Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes Mellitus (2015) (89)
- Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use. (2009) (86)
- Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events (2006) (85)
- Interaction of Body Mass Index and Framingham Risk Score in Predicting Incident Coronary Disease in Families (2005) (85)
- Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk. (2016) (83)
- Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial (2015) (78)
- Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. (2007) (78)
- The Metabolic Syndrome in Women (2006) (77)
- Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement (2022) (75)
- Paradoxical Association of Lipoprotein Measures With Incident Atrial Fibrillation (2014) (71)
- Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence: Prospective Data From the Women’s Health Study (2018) (69)
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. (2020) (65)
- Lipoprotein(a) and Cardiovascular Risk Prediction Among Women. (2018) (64)
- Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment. (2016) (64)
- Association of Air Pollution Exposures With High-Density Lipoprotein Cholesterol and Particle Number: The Multi-Ethnic Study of Atherosclerosis (2017) (61)
- On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). (2012) (58)
- Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women. (2017) (57)
- The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. (2010) (57)
- Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment. (2019) (54)
- Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The JUPITER Trial (2015) (54)
- A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study. (2013) (53)
- Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins (2017) (52)
- Assessment of Risk Factors and Biomarkers Associated With Risk of Cardiovascular Disease Among Women Consuming a Mediterranean Diet (2018) (51)
- High-Density Lipoprotein Particle Subclass Heterogeneity and Incident Coronary Heart Disease (2014) (51)
- Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health Initiative (2018) (50)
- Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study (2019) (50)
- Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER). (2014) (49)
- Directed Non-targeted Mass Spectrometry and Chemical Networking for Discovery of Eicosanoids and Related Oxylipins. (2018) (48)
- Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State. (2015) (48)
- Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA‐3 TriaL (VITAL) (2020) (47)
- The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design (2020) (47)
- Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial. (2016) (47)
- Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women. (2021) (47)
- Circulating N‐Linked Glycoprotein Side‐Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial (2016) (44)
- Dietary Intakes and Circulating Concentrations of Branched-Chain Amino Acids in Relation to Incident Type 2 Diabetes Risk Among High-Risk Women with a History of Gestational Diabetes Mellitus. (2018) (44)
- Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. (2021) (43)
- Nonfasting for Routine Lipid Testing: From Evidence to Action. (2016) (43)
- Markers of Inflammation and Incident Breast Cancer Risk in the Women’s Health Study (2018) (40)
- Association of Nonfasting vs Fasting Lipid Levels With Risk of Major Coronary Events in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm. (2019) (40)
- Association of High-Density Lipoprotein Cholesterol With Incident Cardiovascular Events in Women, by Low-Density Lipoprotein Cholesterol and Apolipoprotein B100 Levels (2011) (39)
- Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]). (2016) (38)
- Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women's Health Study. (2017) (38)
- Lipoprotein subclass abnormalities and incident hypertension in initially healthy women. (2011) (38)
- Biomarkers for prediction of cardiovascular events. (2007) (37)
- Statistical Workflow for Feature Selection in Human Metabolomics Data (2019) (37)
- Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease: Shared Decision Making in Clinical Practice. (2016) (36)
- Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence (2020) (35)
- Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment. (2019) (35)
- Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text (2019) (32)
- Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL). (2014) (28)
- A national interactive web-based physical activity intervention in women, evaluation of the american heart association choose to move program 2006-2007. (2012) (27)
- Supplementation with Vitamin D and/or Omega-3 Fatty Acids and Incidence of Heart Failure Hospitalization: VITAL-Heart Failure. (2019) (26)
- Response to letter regarding article, "lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)". (2014) (26)
- Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality (2016) (26)
- Fasting for lipid testing: is it worth the trouble?: comment on "fasting time and lipid levels in a community-based population". (2012) (25)
- Fasting for lipid testing: Is it worth the trouble? (2012) (25)
- Effects of a low-carbohydrate diet on insulin-resistant dyslipoproteinemia—a randomized controlled feeding trial (2021) (25)
- Clinical decisions. The guidelines battle on starting statins. (2014) (25)
- Altered branched chain amino acid metabolism: toward a unifying cardiometabolic hypothesis (2018) (24)
- Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review. (2022) (23)
- GlycA, a novel inflammatory marker, is associated with subclinical coronary disease (2018) (22)
- Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women (2017) (20)
- Gender-Specific Prediction of Cardiac Disease: Importance of Risk Factors and Exercise Variables (2006) (20)
- Effects of statins on the immunoglobulin G glycome. (2017) (20)
- Nonfasting Sample for the Determination of Routine Lipid Profile: Is It an Idea Whose Time Has Come? (2016) (20)
- Effects of One Year of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Biomarkers of Systemic Inflammation in Older US Adults. (2019) (19)
- Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study (2014) (19)
- Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: The Multi‐Ethnic Study of Atherosclerosis (2018) (19)
- Re-assessing the role of non-fasting lipids; a change in perspective. (2016) (19)
- Circulating branched-chain amino acids and long-term risk of obesity-related cancers in women (2020) (18)
- The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis. (2019) (18)
- Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment. (2019) (17)
- Association of the Mediterranean Diet With Onset of Diabetes in the Women’s Health Study (2020) (17)
- Concordance of Cardiovascular Risk Factors and Behaviors in a Multiethnic US Nationwide Cohort of Married Couples and Domestic Partners (2020) (17)
- Aspirin therapy in primary prevention: comment on "effect of aspirin on vascular and nonvascular outcomes". (2012) (16)
- Marine n-3 fatty acids and prevention of cardiovascular disease and cancer (2019) (16)
- GlycA, a Novel Inflammatory Marker and Its Association With Peripheral Arterial Disease and Carotid Plaque: The Multi-Ethnic Study of Atherosclerosis (2019) (15)
- Abstract 10170: Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis From the JUPITER Trial (2013) (14)
- Group IIA Secretory Phospholipase A2, Vascular Inflammation, and Incident Cardiovascular Disease. (2019) (14)
- Clinical Characteristics and Severity of COVID-19 Disease in Patients from Boston Area Hospitals (2020) (13)
- Association of High‐Density Lipoprotein‐Cholesterol Versus Apolipoprotein A‐I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer‐Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study (2017) (13)
- Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot. (2016) (13)
- Premature Myocardial Infarction in the Middle East and North Africa: Rationale for the Gulf PREVENT Study (2020) (13)
- Hypothyroidism and kidney function - a Mendelian Randomization study. (2020) (13)
- Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review (2019) (13)
- Habitual Fish Consumption, n‐3 Fatty Acids, and Nuclear Magnetic Resonance Lipoprotein Subfractions in Women (2020) (13)
- SARS2 simplified scores to estimate risk of hospitalization and death among patients with COVID-19 (2020) (12)
- Providing patients with global cardiovascular risk information: is knowledge power? (2010) (12)
- Quantum approximate Bayesian computation for NMR model inference (2019) (12)
- Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement (2019) (11)
- Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL. (2020) (11)
- Branched-Chain Amino Acids and Risk of Breast Cancer (2020) (11)
- Risk factors associated with premature myocardial infarction: a systematic review protocol (2019) (11)
- Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women (2021) (10)
- Discordance of LDL Cholesterol with Alternative LDL-Related Measures and Future Coronary Events (2013) (10)
- Cholesterol Insights and Controversies From the UK Biobank Study. (2019) (10)
- Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals (2021) (10)
- Genetic associations with lipoprotein subfraction measures differ by ethnicity in the multi-ethnic study of atherosclerosis (MESA) (2017) (9)
- Diabetes Mellitus, Race, and Effects of Omega-3 Fatty Acids on Incidence of Heart Failure Hospitalization. (2022) (9)
- One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL) (2020) (9)
- Anti‐Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial (2020) (9)
- Clinical Implications of Discordance Between LDL Cholesterol and LDL Particle Number (2011) (8)
- Abstract 17731: Protein Glycan Side-Chains, Rosuvastatin Therapy, and Incident Vascular Events: An Analysis from the JUPITER Trial (2014) (8)
- Gene-Based Elevated Triglycerides and Type 2 Diabetes Mellitus Risk in the Women’s Genome Health Study (2019) (8)
- Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement. (2019) (8)
- Risk Factors for Premature Myocardial Infarction: A Systematic Review and Meta-analysis of 77 Studies (2021) (8)
- Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL) (2021) (8)
- Adiposity and Genetic Factors in Relation to Triglycerides and Triglyceride-Rich Lipoproteins in the Women's Genome Health Study. (2018) (8)
- Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach (2018) (7)
- Lifelong low Lp(a) levels: genetics give a green light? (2021) (7)
- HDL cholesterol, size, particle number, and residual vascular risk after potent statin therapy: the JUPITER trial (2013) (7)
- Association of HDL Cholesterol with Incident Cardiovascular Events by LDL Cholesterol and Apolipoprotein B100 in Women (2011) (7)
- Are there sex differences in acute coronary syndrome presentation?: a guide through the maze. (2013) (7)
- Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): An Overlooked Form of Hypoglycemia in Clinical Practice (2018) (7)
- SARS2 simplified scores to estimate risk of hospitalization and death among patients with COVID-19 (2021) (7)
- Association of obesity indices with in-hospital and 1-year mortality following acute coronary syndrome (2020) (7)
- What's different about women's health? (2014) (7)
- Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial (2022) (7)
- Marine Omega-3 Fatty Acids and Cardiovascular Disease Prevention: Seeking Clearer Water. (2021) (6)
- Elevated C-reactive protein in high-risk asymptomatic individuals is strongly associated with the metabolic syndrome (2003) (6)
- Probabilistic identification of saccharide moieties in biomolecules and their protein complexes (2020) (6)
- Red blood cell fatty acid patterns from 7 countries: Focus on the Omega-3 index. (2022) (6)
- Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein–Related Measures (2015) (6)
- Value of reserve pulse pressure in improving the risk stratification of patients with normal myocardial perfusion imaging. (2013) (6)
- Coronary artery disease in postmenopausal women (2001) (6)
- Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms (2022) (6)
- Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease. (2006) (6)
- The Future of Low-Density Lipoprotein Cholesterol in an Era of Nonfasting Lipid Testing and Potent Low-Density Lipoprotein Lowering (2018) (6)
- Abstract 18807: Novel Protein Glycan Derived Biomarker is Associated With Incident Diabetes (2013) (6)
- Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease (2022) (5)
- Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy (2018) (5)
- Aspirin therapy in women: back to the ABCs. (2009) (5)
- CHAPTER 13 – Use of High-Sensitivity C-Reactive Protein for Risk Assessment (2009) (5)
- Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease. (2019) (5)
- Glycosylation and Cardiovascular Diseases. (2021) (5)
- Focus on Cardiovascular Disease (2019) (5)
- Association of High‐Density Lipoprotein Particles and High‐Density Lipoprotein Apolipoprotein C‐III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi‐Ethnic Study of Atherosclerosis (2019) (5)
- Fasting for Laboratory Tests Poses a High Risk of Hypoglycemia in Patients with Diabetes: A Pilot Prevalence Study in Clinical Practice (2016) (5)
- Fasting status and metabolic health in relation to plasma branched chain amino acid concentrations in women. (2020) (4)
- Marine n-3 Fatty Acids and Vitamin D Supplementation and Primary Prevention. Reply. (2019) (4)
- Certain cardiac risk factors predict risk factor interventions and influence communication between physicians and patients. (2000) (4)
- Effects of thyroid function on hemostasis, coagulation, and fibrinolysis: a Mendelian Randomization study. (2021) (4)
- Is it time to abandon fasting for routine lipid testing? (2017) (4)
- Phenotypic and Genotypic Associations Between Migraine and Lipoprotein Subfractions (2021) (4)
- Association of Physical Activity With Bioactive Lipids and Cardiovascular Events (2022) (4)
- Are advanced lipoprotein testing and subfractionation clinically useful (2009) (3)
- Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)". (2015) (3)
- Perspectives on the Changing Landscape of Measuring Cardiovascular Risk Related to LDL. (2019) (3)
- Lp(a)'s Odyssey: Should We Measure Lp(a) Post-ACS and What Should We Do With the Results? (2020) (3)
- A Prospective Comparison of NMR-Measured LDL Particle Number, Apolipoprotein B100, and Standard Lipids with Incident CHD in 27,673 Initially Healthy Women (2007) (3)
- Multivitamins in the prevention of cancer and cardiovascular disease: The COSMOS randomized clinical trial. (2022) (3)
- Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo. (2022) (3)
- Nonfasting Lipids for All Patients? (2020) (3)
- ATHEROGENIC LIPOPROTEIN PARTICLE SUBCLASSES AND RESIDUAL CARDIOVASCULAR RISK: AN ANALYSIS OF THE JUPITER TRIAL (2015) (3)
- Sugar-Sweetened Beverage Consumption May Modify Associations Between Genetic Variants in the CHREBP (Carbohydrate Responsive Element Binding Protein) Locus and HDL-C (High-Density Lipoprotein Cholesterol) and Triglyceride Concentrations (2021) (3)
- Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease: The Aspirin Dilemma. (2022) (2)
- Misperceptions and management of risk: Ongoing challenges in women's cardiovascular health. (2021) (2)
- A NOVEL BIOMARKER OF CIRCULATING GLYCOPROTEINS AND CARDIOVASCULAR AND ALL-CAUSE MORTALITY AMONG 39,521 INITIALLY HEALTHY ADULTS (2015) (2)
- Sugar-sweetened Beverage Consumption May Modify Associations between Genetic Variants in the CHREBP Locus and HDL-C and TG Concentrations. (2021) (2)
- Abstract 1462: Association of HDL Cholesterol and Apolipoprotein A-1 With Incident CVD Across Levels of LDL Cholesterol in 27,748 Women (2009) (2)
- Abstract 16055: Lipoprotein Subclasses, Size, and Statin-Associated Incident Diabetes: An Analysis From the JUPITER Trial (2014) (2)
- Biphasic Pulmonary Regurgitation (2009) (2)
- Fibroblast growth factor-21 levels in metabolic syndrome: Another instrument in a widening tool belt? (2019) (2)
- Association of Body Weight With Response to Vitamin D Supplementation and Metabolism (2023) (2)
- University of Groningen Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk (2011) (2)
- Abstract 9882: Post-Exercise Blood Pressure Predicts Future Cardiovascular Mortality in Asymptomatic Individuals (2012) (2)
- Consensus and guidelines on lipoprotein(a) – seeing the forest through the trees (2022) (2)
- SAFETY PROFILE OF STATIN-TREATED PATIENTS WITH LDL-C < 30MG/DL (2012) (2)
- Moving beyond mean glycemia: 1,5-anhydroglucitol and microvascular complications of diabetes. (2014) (2)
- Identifying risk factors for premature CAD (2001) (2)
- Discovery and Refinement Supplementary (2015) (1)
- Abstract 17959: Paradoxical Association of LDL Measures With the Risk of Incident Atrial Fibrillation (2013) (1)
- Sugar-sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in U.S. Adults. (2022) (1)
- Non-fasting blood testing for lipid screening in children result in statistically significant, but not clinically significant, changes in lipid levels (2012) (1)
- Residual risk in TNT (2012) (1)
- Predicting Asthma Exacerbations from a Drop of Blood. (2017) (1)
- The association of cardiovascular mortality with a first-degree family member history of different cardiovascular diseases (2021) (1)
- Lifestyle InteractionWith FatMass and Obesity-Associated ( FTO ) Genotype and Risk of Obesity in Apparently Healthy U . S . Women (2011) (1)
- Abstract 13479: Association of Plasma Branched Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women (2020) (1)
- Statistical Methods and Workflow for Analyzing Human Metabolomics Data. (2017) (1)
- Abstract P280: Revisiting CVD Risk Prediction Using Machine Learning Approaches: A Case Study (2020) (1)
- The Metabolic Syndrome as a Cluster of Risk Factors (2017) (1)
- Abstract 18502: Mass and Genetic Polymorphism of Group IIA Secretory Phospholipase A2, Rosuvastatin Therapy, and Risk of Cardiovascular Events: An Analysis From the JUPITER Trial (2015) (1)
- Abstract 019: Modifiable Lifestyle Factors And Plasma Branched Chain Amino Acids: An Analysis Of N=19,472 US Women (2021) (1)
- Probabilistic identification of saccharide moieties in biomolecules and their protein complexes (2020) (1)
- Abstract 3936: Homocysteine Concentration, 5, 10-Methylenetetrahydrofolate Reductase 677C>T Gene Polymorphism, and Intake of Folate and B-Vitamins in 24,968 Asymptomatic Women (2006) (1)
- Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis. (2023) (1)
- Exercise Treadmill Stress Testing With and Without Imaging (2011) (1)
- Abstract 18720: HDL Particle Subclasses, Rosuvastatin Therapy, and Risk of Vascular Events: An Analysis From the JUPITER Trial (2015) (1)
- The Curious Case of Synergy between Lipoprotein (a), Coronary Calcification, and Cardiovascular Disease Risk. (2022) (1)
- The exercise tolerance test predicts future cardiovascular and all-cause death in asymptomatic women (2002) (1)
- Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular American Academy of Family Physicians; American Association of Prevention of Cardiovascular Disease): Developed in Collaboration With the Measures (Writing Committee to Develop Performance Measures for Primary Cardiology Foun (2009) (1)
- Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial (2022) (1)
- Effects of a Low-Carbohydrate Diet on Cardiometabolic Risk Factors During Weight-Loss Maintenance: A Randomized Controlled Feeding Trial (2020) (1)
- Abstract 20653: Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort of Women: The Women’s Health Initiative (2017) (1)
- The Inflammation Biomarker GlycA Reflects Plasma N-Glycan Branching. (2022) (1)
- Blood pressure and risk of developing type 2 diabetes mellitus : The Women's Health Study. Commentary (2007) (1)
- Abstract 18739: Novel Protein Glycan Derived Marker of Systemic Inflammation is Associated With Incident Cardiovascular Disease (2013) (1)
- Response to Letter Regarding Article, “Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women” (2009) (1)
- Assessing the dyslipidemias: to fast or not to fast? (2021) (1)
- Mediterranean Diet Social Network Impact along 11 Years in the Major US Media Outlets: Thematic and Quantitative Analysis Using Twitter (2022) (1)
- Zareen Farukhi and Samia Mora and Potent Low-Density Lipoprotein Lowering The Future of Low-Density Lipoprotein Cholesterol in an Era of Nonfasting Lipid Testing (2017) (0)
- Aspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women. (2022) (0)
- Risk and Benefit Information and Use of Aspirin-Reply. (2017) (0)
- Abstract 17400: Using Electronic Health Records for Predicting Hospitalization of COVID-19 Patients in Massachusetts (2020) (0)
- Abstract P040: GlycA, a Novel Inflammatory Marker, and Subclinical Coronary Atherosclerosis in the Multicenter AIDS Cohort Study (MACS) (2018) (0)
- Genetic associations with lipoprotein subfraction measures differ by ethnicity in the multi-ethnic study of atherosclerosis (MESA) (2017) (0)
- What Are Advanced Lipoprotein Tests Often Used for in Clinical Practice ? (2009) (0)
- Identification and targeting of genes in atherosclerosis (2017) (0)
- Abstract 17662: Nonfasting Compared With Fasting Lipids for Predicting Major Coronary Events in ASCOT-LLA (2016) (0)
- Abstract 18416: Discordance Between nonHDLc and Lipoprotein Particle Concentration (apoB and LDLp) in Relation to Future Coronary Events in Women (2015) (0)
- Abstract 11184: High Concordance of Non-ideal Cardiovascular Health Metrics in a Nation-wide Study of 5,364 Spouse-pairs (2019) (0)
- Abstract WP219: The Relationship of Low-Density Lipoprotein (LDL) Particle Number (LDL-P) and LDL Particle Size and Incident Stroke Events: The Multi-Ethnic Study of Atherosclerosis (2017) (0)
- Effects of Vitamin D3 Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL (2022) (0)
- Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart Disease. (2022) (0)
- EXERCISE-INDUCED VENTRICULAR ECTOPY AND FUTURE CARDIOVASCULAR DEATH IN ASYMPTOMATIC INDIVIDUALS: A 20-YEAR FOLLOW-UP OF THE LIPID RESEARCH CLINICS PREVALENCE STUDY (2021) (0)
- Abstract 746: Branched-chain amino acids and risk of breast cancer by menopausal status in three large cohorts (2021) (0)
- Abstract 37: Lipoprotein Subclasses and Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (2014) (0)
- Abstract 10909: LDL and HDL Particle vs. Cholesterol Concentration in Metabolic Syndrome and Diabetes for the Prediction of Coronary Heart Disease: The Multiethnic Study of Atherosclerosis (2015) (0)
- ASSOCIATION BETWEEN SERUM CALCIUM AND COGNITIVE FUNCTION IN HEALTHY PEOPLE AGED 60 OR OLDER IN THE VITAL STUDY (2016) (0)
- Social Determinants of Health and Mortality After Premature and Non-premature Acute Coronary Syndrome (2023) (0)
- Shared Decision Making Regarding Aspirin in Primary Prevention of Cardiovascular Disease-Reply. (2016) (0)
- Abstract 5000: A Prospective Examination of the Association of Nuclear Magnetic Resonance Measured Lipoprotein Particles with Incident Hypertension in the Women's Health Study (2008) (0)
- Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial (2022) (0)
- P619Incident premature coronary heart disease in women: an analysis of 53 biomarkers from the Women's Health Study (2018) (0)
- Does the presence of certain cardiac risk factors positively influence risk factor interventions (1998) (0)
- Fish consumption, omega-3 fatty acids (n-3), and nmr lipoprotein subfractions in 26034 apparently healthy women (2015) (0)
- 193 COMPARISON OF THEORETICAL AND EXPERIMENTAL RELATIONSHIPS BETWEEN HDL SIZE AND THE RATIO OF HDL CHOLESTEROL (HDL-C) TO APOLIPOPROTEIN A-I (APOA-I) (2011) (0)
- Abstract 16471: Lipoprotein(a) Cholesterol and Cardiovascular Events in the VITamin D and OmegA 3 TriaL (Vital) (2020) (0)
- The Association of HDL-C vs Apolipoprotein A-I with Risk of Coronary Heart Disease (2017) (0)
- Abstract 630: Lipoprotein Subclasses by Ion Mobility and First Cardiovascular Events: An Analysis of 11,227 Participants From the JUPITER Trial (2014) (0)
- Abstract 13189: Effects of Marine Omega-3 Supplementation on Fatty Acids and Bioactive Lipids and Associations With Risk of Cardiovascular Disease: Secondary Analysis From the Randomized Vitamin D and Omega-3 Trial (VITAL) (2019) (0)
- Patient-physician-medical record disagreement on cardiovascular risk factor management (1998) (0)
- WiNN: Drift correction by white noise normalization for metabolomic studies (2020) (0)
- Abstract 15658: Determinants of Residual Risk in 9,251 Secondary Prevention Patients Treated with High- versus Low-dose Statin Therapy: The Treating to New Targets (TNT) Study (2011) (0)
- Routine Clinical Use Advanced Lipoprotein Testing and Subfractionation Are Not (Yet) Ready for (2009) (0)
- Echocardiography for cardiac surgery (2018) (0)
- Adding Exercise Testing to Framingham Score for Cardiovascular Risk Assessment (2005) (0)
- LDL PARTICLE SIZE : DOES IT MATTER ? (0)
- Serum Vitamin D: Correlates of Baseline Concentration and Response to Supplementation in VITAL-DKD. (2021) (0)
- CARDIOVASCULAR DISEASE MORTALITY AND ITS ASSOCIATION WITH PATERNAL, MATERNAL AND SIBLING HISTORY OF DISEASES AN 18-YEAR FOLLOW-UP STUDY (2021) (0)
- Level of Exercise and Risk of Cardiovascular Disease—Reply (2004) (0)
- Mediterranean diet social network impact along 11 years in the major US media outlets: Thematic and Quantitative Analysis using Twitter. (Preprint) (2020) (0)
- LEISURE-TIME PHYSICAL ACTIVITY ASSOCIATES FAVORABLY WITH THE BIOACTIVE LIPIDOME AND RISK OF INCIDENT CVD EVENTS/ RESULTS FROM THE VITAMIN D AND OMEGA-3 TRIAL (VITAL) AND JUPITER TRIALS (2021) (0)
- Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults (2022) (0)
- From the EAS:* frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society (2023) (0)
- Lipoprotein(A) Predicts Cardiovascular Events In Statin Outcome Trials: Pooled Analysis Of Seven Randomised Controlled Trials (2019) (0)
- Background—It is unclear whether levels of high-density lipoprotein cholesterol (HDL-C) or apolipoprotein A-I (apoA-I) remain inversely associated with cardiovascular risk among patients who achieve very low levels of low-density lipoprotein cholesterol on statin therapy. It is also unknown whether (2013) (0)
- Abstract B79: Novel protein glycan biomarker and future colorectal cancer (2016) (0)
- Abstract 40: Score Based on Immunoglobulin G N-glycans for Cardiovascular Risk Prediction: Secondary Analysis of Two Randomized Trials of Primary and Secondary Prevention (2023) (0)
- Abstract 11848: Biomarkers of Glucose-Insulin Homeostasis, Randomized Treatment With Omega-3 and Vitamin D Supplementation, and Incident Type 2 Diabetes: Prospective Analysis From the Vitamin D and Omega-3 Trial (VITAL) (2021) (0)
- Abstract 20246: Impact of Subclinical Hypothyroidism on Lipid and Lipoprotein Subclasses (2014) (0)
- Abstract 4023: Do Known Risk Factors Explain the Inverse Relation Between Physical Activity and Cardiovascular Disease Risk? (2006) (0)
- Analyzing Mediterranean diet on Twitter: a 11-year analysis of tweets from the major US media outlets. (Preprint) (2020) (0)
- W26 DISCORDANCE BETWEEN LDL CHOLESTEROL AND LDL PARTICLE CONCENTRATION IN RELATION TO INCIDENT CVD EVENTS IN 27673 WOMEN (2010) (0)
- Response to letter regarding article, "High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy". (2014) (0)
- Partitioning the Genetic Architecture of Plasma Lipoprotein(a) and Kringle IV Type 2 Repeats: Implications for Therapeutic Lowering. (2017) (0)
- CLINICAL DETERMINANTS OF INCIDENT AORTIC STENOSIS IN STATIN–TREATED STABLE CORONARY PATIENTS (2013) (0)
- Abstract 12828: Mediterranean Diet and Reduced Risk of Cardiovascular Disease: Potential Mediating Mechanisms (2018) (0)
- High specificity and negative predictive value of exercise testing for long-term mortality in asymptomatic men (2002) (0)
- Abstract 17747: Associations of Ideal Cardiovascular Health by AHA Life Simple 7 Criteria With N-Linked Glycoprotein Acetyl (GlycA), a Novel Inflammatory Marker: The Multi-Ethnic Study of Atherosclerosis (MESA) (2017) (0)
- Abstract 16278: Discordant Lipid Phenotype and Other Determinants of Statin Response in the Pravastatin Inflammation/crp Evaluation (PRINCE) Trial (2020) (0)
- CHOLESTEROL EFFLUX CAPACITY, HDL-PARTICLE NUMBER, AND INCIDENT CARDIOVASCULAR EVENTS: RESULTS FROM THE JUPITER TRIAL (2016) (0)
- COMBINING MULTIPLE CARDIOVASCULAR RISK PREDICTION MODELS IMPROVES MODEL PERFORMANCE: A NOVEL FLEXIBLE FRAMEWORK APPROACH APPLIED TO A CONTEMPORARY AND DIVERSE EHR COHORT (2022) (0)
- A Still-Ignored Cardiovascular Risk Factor-A History of Preeclampsia-Reply. (2021) (0)
- 1102 Fish oil supplementation and pro-inflammatory and pro-resolving lipid mediators in patients with and without systemic lupus erythematosus (2021) (0)
- Abstract 11268: Fasting Low Density Lipoprotein Cholesterol (LDL-C) Levels Stratified by Fasting Time Do Not Have Significant Improvement in Prognostic Value versus Non-fasting LDL-C (2014) (0)
- Errors in Equation and Modeling Parameter. (2016) (0)
- Abstract P330: Effect of Randomized Omega-3 Treatment on Downstream Bioactive Lipids and Their Association With Incident Cardiovascular Disease Events: Metabolomic Studies of the Vital and Jupiter Trials (2023) (0)
- Abstract P341: A Flexible, Interpretable Approach to Recalibrate Risk Prediction Models: Adapting the Pooled Cohorts Equation to a Local New England Contemporary Population (2023) (0)
- Clinical determinants of incident aortic valve stenosis in patients treated with atorvastatin: results from three large randomized clinical trials (2013) (0)
- Abstract 13310: Anti-Inflammatory HDL Function and Incident Cardiovascular/Death Events: A Secondary Analysis of the JUPITER Trial (2018) (0)
- Left Ventricular Noncompaction/ Hypertrabeculation: Distinctive Entity or Abnormality, Frequently (2011) (0)
- Abstract P260: Determinants of Statin Response: A Secondary Analysis of the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) (2020) (0)
- Abstract P346: Novel Protein Glycan Derived Marker of Systemic Inflammation is Associated with Incident Coronary Heart Disease and Ischemic Stroke (2014) (0)
- Abstract 13397: Determining the Optimal Cutpoint Value for the Diagnosis of Hypertriglyceridemia in the Nonfasting Population (2014) (0)
- Abstract 17304: Web-Based 12-Week Activity Intervention (American Heart Association Choose to Move Program) Improved Compliance with Guideline Recommendations (2010) (0)
- Abstract: 1470 SHOULD APOB OR LDL PARTICLE CONCENTRATION REPLACE STANDARD LIPIDS FOR PRIMARY PREVENTION OF CVD? (2009) (0)
- Abstract 1093: A Prospective Comparison of NMR-Measured Large Versus Small LDL particles with Incident CHD in 27,673 Initially Healthy Women (2007) (0)
- Association of modifiable lifestyle factors with plasma branched chain amino acid metabolites in women. (2022) (0)
- A little more time around the track may go a long way: Implications of increasing moderate to vigorous physical activity in pre-adolescents. (2019) (0)
- 13-OR: Effects of Randomized Statin Therapy vs. Placebo on Plasma Branched-Chain Amino Acids (BCAAs) and Type 2 Diabetes (T2D) Risk: Secondary Analysis of the JUPITER Trial (2021) (0)
- Risk of type 2 diabetes mellitus in those with hypertension: reply (2008) (0)
- Reply to Ramírez PC and Diaz-Quijano FA (AJCN-D-22-00631). (2022) (0)
- Mediterranean Diet And Reduced Risk Of Diabetes: Potential Mediating Mechanisms (2019) (0)
- Abstract 2178: Does Lifestyle Modify the Genetic Risk of Obesity? An Association Study of Lifestyle Interactions With FTO Genotype in 21,675 Caucasian Women (2009) (0)
- Abstract 1426: Rosuvastatin for the Primary Prevention of Cardiovascular Events in Women With Elevated hsCRP and Low LDLC: Sex-Specific Outcomes From the JUPITER Trial (2009) (0)
- Abstract 14943: Comparison of Fasting and Nonfasting Lipoprotein Subfractions and Size in 13,460 Apparently Healthy Individuals (2017) (0)
- RESIDUAL RISK AND ON-STATIN REDUCTIONS IN TRIGLYCERIDES, REMNANT CHOLESTEROL, AND VLDL LIPOPROTEINS: AN ANALYSIS FROM THE JUPITER TRIAL (2016) (0)
- Abstract P021: Performance Of Pooled Cohort Equations And MESA Risk Score Across Race/Ethnicity And Socioeconomic Status To Estimate 10-year Cardiovascular Risk In Diverse New England Cohort (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Samia Mora?
Samia Mora is affiliated with the following schools: